Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
52.99
+1.47 (2.85%)
At close: Sep 18, 2025, 4:00 PM EDT
53.69
+0.70 (1.32%)
After-hours: Sep 18, 2025, 6:42 PM EDT
Bio-Techne Revenue
In the fiscal year ending June 30, 2025, Bio-Techne had annual revenue of $1.22B with 5.23% growth. Bio-Techne had revenue of $316.96M in the quarter ending June 30, 2025, with 3.55% growth.
Revenue (ttm)
$1.22B
Revenue Growth
+5.23%
P/S Ratio
6.84
Revenue / Employee
$393,431
Employees
3,100
Market Cap
8.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 1.22B | 60.58M | 5.23% |
Jun 30, 2024 | 1.16B | 22.36M | 1.97% |
Jun 30, 2023 | 1.14B | 31.10M | 2.81% |
Jun 30, 2022 | 1.11B | 174.57M | 18.75% |
Jun 30, 2021 | 931.03M | 192.34M | 26.04% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TECH News
- 8 days ago - Bio-Techne Corporation (TECH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Bio-Techne Corporation (TECH) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 9 days ago - ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California - PRNewsWire
- 15 days ago - Bio-Techne Corporation (TECH) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Bio-Techne to Present at Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory - PRNewsWire
- 6 weeks ago - Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Bio-Techne beats quarterly estimates on strength in protein sciences unit - Reuters